15.06.2014 Views

Rule of 30, Shock index and

Rule of 30, Shock index and

Rule of 30, Shock index and

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

New aspects - treating severe PPH<br />

• General remarks<br />

• New methods<br />

•Drugs<br />

•Balloons<br />

•Radiology<br />

•Surgery<br />

• <strong>Rule</strong> <strong>of</strong> <strong>30</strong>, <strong>Shock</strong> <strong>index</strong> <strong>and</strong><br />

”the golden hour”<br />

• Post PPH<br />

•Intravenous iron


Post partum hemorrhage - PPH<br />

> 500 ml/24 hrs<br />

3-5% <strong>of</strong> vaginal births<br />

5-7% <strong>of</strong> CS<br />

> 1000 ml/24 hrs<br />

0.5-2% <strong>of</strong> all deliveries


PPH - Risk factors<br />

Previous PPH<br />

Antenatal bleeding<br />

Polyhydramnios, twins, macrosomia<br />

Protracted labour<br />

Placenta praevia (marginalis)<br />

High age <strong>and</strong>/or BMI<br />

PE, DIC, IUFD, Abruption


PPH - prophylaxis<br />

Active management <strong>of</strong> 3rd stage<br />

Oxytocin i.m. - after anterior<br />

shoulder is delivered<br />

Cord clamped <strong>and</strong> cut at once<br />

Light cord traction<br />

Reduces severe PPH by 2/3


PPH prophylaxis in Norway 2001<br />

Maternity units<br />

Hospitals N n %<br />

University 7 4 57<br />

Level 2 10 7 70<br />

Other 29 11 38<br />

Midwife led units 9 4 44<br />

Total 55 26 47<br />

Bjørnerem et al. Tidsskr Nor Lægeforen 2002;122:2536-7


PPH - causes<br />

Remember the 4 T’s !<br />

Tone - uterine atony 70%<br />

Tissue - retained placenta 20%<br />

Tears - vagina/cervix 10%<br />

Thrombin - coagulopathy


PPH - initial steps<br />

Call for help<br />

I.v. access (2 green/gray i.v. bores)<br />

ABC, monitor BP, pulse, respiration<br />

Bimanual compression <strong>of</strong> uterus<br />

Uterotonics (Oxytocin & Misoprostol)<br />

Check Hb, platelets - blood avaialable<br />

Proceed to advanced methods


Algorithm for management <strong>of</strong> Atonic PPH<br />

H Ask for Help<br />

HAEMOSTASIS<br />

A Assess (vital parameters, blood loss) <strong>and</strong><br />

resuscitate<br />

E Establish etiology + Ensure availability <strong>of</strong><br />

blood<br />

M Massage uterus<br />

O Oxytocin infusion + Prostagl<strong>and</strong>ins<br />

intravenous/ per rectal/ intramuscular/<br />

intra-myometrial


Prostagl<strong>and</strong>in potentiates the<br />

action <strong>of</strong> oxytocin<br />

Stepwise quick progression<br />

Oxytocin <strong>and</strong>/or Ergometrine infusion<br />

Prostagl<strong>and</strong>ins IV; IM; IntraMyometrial<br />

Misoprostol 800 ug rectally/400 ug orally<br />

whilst using oxytocin infusion


New drug: rFVIIa (NovoSeven R )<br />

Tissue factor via extrinsic pathway<br />

Binds to platelets <strong>and</strong> activates FX


FVIIa (NovoSeven R )<br />

Recommended - 1,5 X blood volume lost<br />

Dose: 70 kg - 90 µg/kg - NOK 40 000,-<br />

Reduced effect<br />

Thrombocytopenia (platelets > 50 000)<br />

Low fibrinogen (fibrinogen > 1 g/l)<br />

Hypothermia<br />

Acidosis (pH < 7.1)<br />

Review - Int J Obstet Anesth 2007;16:29-34


Algorithm for management <strong>of</strong> Atonic PPH<br />

HAEMOSTASIS<br />

S <strong>Shock</strong> Garment & Shift to theatre – exclude<br />

Tissue or Trauma / Bimanual compression<br />

T Tamponade – Balloon or uterine packing<br />

A Apply compression sutures<br />

B-Lynch or modified<br />

S Systematic Pelvic devascularisation<br />

<br />

Uterine/Ovarian/Quadruple/Internal iliac<br />

I Interventional Radiologist<br />

If appropriate uterine artery embolisation<br />

S Subtotal / Total abdominal hysterectomy


Algorithm for management <strong>of</strong> Atonic PPH<br />

HAEMOSTASIS<br />

S <strong>Shock</strong> Garment & Shift to theatre – exclude<br />

Tissue or Trauma / Bimanual compression<br />

T Tamponade – Balloon or uterine packing<br />

A Apply compression sutures<br />

B-Lynch or modified<br />

S Systematic Pelvic devascularisation<br />

<br />

Uterine/Ovarian/Quadruple/Internal iliac<br />

I Interventional Radiologist<br />

If appropriate uterine artery embolisation<br />

S Subtotal / Total abdominal hysterectomy


Literature Review <strong>of</strong> the conservative<br />

surgical (& radiological) measures<br />

Series <strong>of</strong> at least 5 cases<br />

English language<br />

Single interventions<br />

Uterine ballon tamponade<br />

B-Lynch/ compression sutures<br />

Arterial embolization<br />

Int. iliac artery ligation/ uterine<br />

devascularization<br />

Success rates


Condous G et al. Obstet Gynecol 2003; 101: 767-72<br />

The “Tamponade Test”<br />

Therapeutic<br />

No further intervention in 14 <strong>of</strong> 16 PPH<br />

Continue oxytocin infusion for 12 hrs,<br />

small vaginal pack, IV antibiotics, check<br />

fundal height <strong>and</strong> bleeding<br />

Prognostic<br />

The need to do a laparotomy - answer<br />

known in few minutes


Uterine balloon tamponade


Uterine balloon tamponade<br />

Authors Year Type <strong>of</strong> study Method No <strong>of</strong><br />

women<br />

Success Rates<br />

Goldrath 1983 Case series Foley catheter 20 19/20 (95%)<br />

Bakri et al 2001 Case series Silicone Balloon 5 3*/5 (60%)<br />

Condous et al 2003 Case series Sengstaken -Blakemore 16 14/16 87.50%<br />

Akhter et al 2003 Case series Condom 23 23/23 (100%)<br />

Penney et al<br />

(Scottish<br />

Audit)****<br />

Penney et al<br />

(Scottish<br />

Audit)****<br />

2003 Audit Balloon 6 5/6 (83.3%)<br />

2004 Audit Balloon 21 15/21 (71.4%)<br />

Seror et al 2005 Case series Sengstaken -Blakemore 17 12/17 (70.6%)<br />

St George’s<br />

ongoing series<br />

2006 Case series Sengstaken -Blakemore 27 22/27 (81.5%)<br />

Total 135 83.7%


COMPRESSION SUTURES<br />

Quick, safe <strong>and</strong> effective<br />

B-Lynch<br />

Horizontal full thickness sutures<br />

Vertical full thickness sutures<br />

Square sutures<br />

Combination <strong>of</strong> sutures


B-Lynch or Compression sutures<br />

Authors Year Type <strong>of</strong> study Method No <strong>of</strong><br />

women<br />

Success Rates<br />

B-Lynch et al 1997 Case series B-Lynch 5 5/5 (100%)<br />

Cho et al 2000 Case series Square sutures 23 23/23 (100%)<br />

Pal et al 2003 Case series B-Lynch 6 6/6 (100%)<br />

Smith et al 2003 Case series B-Lynch 7 6/7 (85.7%)<br />

Penney et al (Scottish<br />

Audit)<br />

Penney at al (Scottish<br />

Audit)<br />

2003 Audit*** B-Lynch 10 9/10 (90%)<br />

2004 Audit*** B-Lynch 19 13/19 (68.4%)<br />

Wohlmuth et al 2005 Case series B-Lynch 12 11/12 (91.6%)<br />

Pereira et al 2005 Case series Compressive<br />

sutures<br />

7 7/7 (100%)<br />

Nelson et al 2006 Case series Modified B-Lynch 5 5/5 (100%)<br />

Total 94 85/94 (90.4 %)


Int. Iliac / Step-wise devascularization<br />

Authors Year Method No <strong>of</strong><br />

women<br />

Success<br />

Rates<br />

Evans et al 1985 Internal iliac artery ligation 14 6/14 (42.8%)<br />

Clark et al 1985 Bilateral hypogastric artery ligation 19 8/19 (42.1%)<br />

Fahmy 1987 Uterine artery ligation 25 20/25 (80%)<br />

Fern<strong>and</strong>ez et al 1988 Internal iliac artery ligation 8 8/8 (100%)<br />

Chattopadhyay<br />

et al<br />

1990 Bilateral hypogastric artery ligation 29 19/29 (65%)<br />

AbdRabbo 1994 Stepwise uterine devascularization 103 103 (100%)<br />

Ledee et al 2001 Bilateral hypogastric artery ligation 48 43/48 (89.5%)<br />

Hebisch et al 2002 Vaginal uterine artery ligation 13 12/13 (92.3%)<br />

Penney et. al**<br />

(Scottish Audit)<br />

2004 Bilateral uterine artery ligation 5 2/5 (40%)<br />

Total 264 83.7%


Arterial embolisation<br />

Authors Year Method No <strong>of</strong><br />

women<br />

Success Rates<br />

Greenwood et al 1987 Multiple pelvic arterial embolization 8 6/8 (75%)<br />

Bakri et al 1992 Arterial embolization 14 14/14 (100%)<br />

Gilbert et al 1992 Bilateral hypogastric artery<br />

embolization<br />

Mitty et al 1993 Int. pudendal <strong>and</strong> uterine artery<br />

embolization<br />

8 8/8 (100%)<br />

8 8/8 (100%)<br />

Yamashita et al 1994 Multiple pelvic arterial embolization 15 15/15 (100%)<br />

Pelage et al 1999 Uterine artery embolization 37 (prim.) 14<br />

(second.)<br />

89%, 97%<br />

Ledee et al 2001 Arterial selective embolization 7 5/7 (71.4%)<br />

Deux et al 2001 Arterial embolization 25 24/25 (96%)<br />

Cheng et al 2003 Arterial embolization 15 12/15 (80%)<br />

Chung et al 2003 Arterial embolization 33 31/33 (94%)<br />

Tourne et al 2003 Uterine artery embolization 12 11/12 (91.6%)<br />

Tsang et al 2004 Arterial embolization 9 9/9 (100%)<br />

Hong et al 2004 Internal iliac artery embolization 7 6/7 (85.7%)<br />

Total 218 91%


Conservative (Surgical) Treatment for PPH<br />

Method No. <strong>of</strong> Cases Success rates<br />

B-Lynch + other<br />

Compression sutures<br />

94 91%<br />

Arterial embolisation 218 91%<br />

Arterial ligation 264 84%<br />

Uterine balloon<br />

tamponade<br />

NovoSeven<br />

(NEFOH)<br />

135 84%<br />

97 80-85%


Algorithm for management <strong>of</strong> Atonic PPH<br />

HAEMOSTASIS<br />

S <strong>Shock</strong> Garment & Shift to theatre – exclude<br />

Tissue or Trauma / Bimanual compression<br />

T Tamponade – Balloon or uterine packing<br />

A Apply compression sutures<br />

B-Lynch or modified<br />

S Systematic Pelvic devascularisation<br />

<br />

Uterine/Ovarian/Quadruple/Internal iliac<br />

I Interventional Radiologist<br />

If appropriate uterine artery embolisation<br />

S Subtotal / Total abdominal hysterectomy


Maternal mortality due to PPH<br />

CONFIDENTIAL ENQUIRY INTO<br />

MATERNAL DEATHS<br />

TOO LITTLE – TOO LATE<br />

Too Little (IV fluids, oxytocics,<br />

BLOOD, Clotting factors)<br />

Too Late (PG, resuscitation -<br />

blood replacement, decision for<br />

surgery + to get senior surgeon &<br />

anaesthetist involved)


Blood loss<br />

ml %<br />

PPH<br />

Symptoms<br />

500-1000 10-15 Slight tachycardia,<br />

palpitations, drowsiness<br />

1000-1500 15-25 Tachycardia, cold &<br />

sweating, malaise<br />

1500-2000 25-35 Uneasy, pale, oligouria<br />

BP 60-80<br />

2000-<strong>30</strong>00 35-45 Severe shock, colapse,<br />

anuria, BP 40-60


<strong>Rule</strong> <strong>of</strong> <strong>30</strong><br />

<strong>30</strong>% blood loss > moderate shock<br />

HR – increase > <strong>30</strong> bpm<br />

Respiratory rate > <strong>30</strong>/min<br />

Systolic BP – down <strong>30</strong> mm Hg<br />

Urinary output < <strong>30</strong> ml/hour<br />

Haematocrit drop > <strong>30</strong>% & to be kept at<br />

an absolute value <strong>of</strong> > <strong>30</strong>


<strong>Shock</strong> <strong>index</strong><br />

<strong>Shock</strong> Index = HR / Systolic BP<br />

Normal = 0.5-0.7<br />

<strong>Shock</strong> <strong>index</strong> > 0.9 indicates state<br />

<strong>of</strong> shock that needs urgent<br />

resuscitation


THE GOLDEN HOUR<br />

As more time elapses between the point<br />

<strong>of</strong> severe shock <strong>and</strong> the start <strong>of</strong><br />

resuscitation, the percentage <strong>of</strong><br />

surviving patient decreases (metabolic<br />

acidosis)<br />

The “Golden Hour” is the time in which<br />

resuscitation must begin to achieve<br />

maximum survival


Subtotal or Total Hysterectomy<br />

Severe hypotension > 20-<strong>30</strong> min<br />

Continued blood loss (>3 L) despite<br />

other surgical measures<br />

Inadequate response to blood<br />

replacement<br />

ECG changes<br />

Placenta praevia/acreta with bleeding<br />

DIC/ Washout phenomenon with<br />

difficulty in getting clotting factors


PPH Coagulation disorders<br />

‘Washout Phenomenon’<br />

DIC - FDP inhibits clotting<br />

“Washout phenomenon” - the<br />

coagulation factors are consumed <strong>and</strong><br />

washed out at the site <strong>of</strong> bleeding<br />

The “washout” is the major<br />

phenomenon that prevents arrest <strong>of</strong><br />

haemorrhage


Intravenous iron post PPH<br />

RCT - Bh<strong>and</strong>all et al. BJOG - nov. 2006<br />

Anaemic (Hb< 9 g/dL) women (N = 44) pp.<br />

intravenous iron vs Fe sulphate po.<br />

Intravenous iron group significant higher<br />

Hb after 5 days, but not after 40 days<br />

Ferritin even after 40 days


Norwegian RCT<br />

Unpublished - in the pipeline - Westad et al<br />

Anaemic (6,5


Intravenous ferric carboxymaltose<br />

compared with oral iron in the<br />

treatment <strong>of</strong> postpartum anemia:<br />

a r<strong>and</strong>omized controlled trial<br />

Van Wyck DB, Martens MG, Seid MH, Baker JB,<br />

Mangione A. Obstet Gynecol 2007;110:267-278


Material & methods<br />

R<strong>and</strong>omized, controlled trial<br />

Anaemic women (Hb


Results<br />

Hb response (≥2.0 g/dL) earlier <strong>and</strong> higher in IV<br />

group vs oral group (p


Conclusions<br />

Large dose IV ferric carboxymaltose is a new<br />

agent that is effective in postpartum anemia<br />

When compared with oral ferrous sulfate<br />

IV ferric carboxymaltose is better tolerated,<br />

prompts a more rapid Hb response <strong>and</strong> corrects<br />

anemia more reliably<br />

Van Wyck et al. Obstet Gynecol 2007;110:267-78


Is Erythropoietin beneficial<br />

in the treatment <strong>of</strong><br />

postpartum anaemia?<br />

No!<br />

Wågstrøm E, Åkesson A, van<br />

Rooijen M, Larson B, Bremme K.<br />

Acta Obstet Gyn Sc<strong>and</strong><br />

2007;86:957-62

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!